ArticleNeoplasia (New York, N.Y.)2015

Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner.

Irina Kiprianova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.